A prognostic risk model for glioma patients by systematic evaluation of genomic variations

The overall survival rate of gliomas has not significantly improved despite new effective treatments, mainly due to tumor heterogeneity and drug delivery. Here, we perform an integrated clinic-genomic analysis of 1, 477 glioma patients from a Chinese cohort and a TCGA cohort and propose a potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Baifeng, Wan, Weiqing, Li, Zibo, Gao, Zhixian, Ji, Nan, Xie, Jian, Wang, Junmei, Wang, Bin, Lai-Wan Kwong, Dora, Guan, Xinyuan, Gao, Shengjie, Zhao, Yuanli, Lu, Youyong, Zhang, Liwei, Rodland, Karin D., Tsang, Shirley X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758519/
https://www.ncbi.nlm.nih.gov/pubmed/36536675
http://dx.doi.org/10.1016/j.isci.2022.105681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758519/
https://www.ncbi.nlm.nih.gov/pubmed/36536675
http://dx.doi.org/10.1016/j.isci.2022.105681

Ejemplares similares